Mead G M, Kushlan P, O'Neil M, Burke J S, Rosenberg S A
Cancer. 1983 Oct 15;52(8):1496-501. doi: 10.1002/1097-0142(19831015)52:8<1496::aid-cncr2820520827>3.0.co;2-1.
From July 1971 to December 1980, 323 cases of non-Hodgkin's lymphoma were randomized into prospective clinical trials at Stanford University Medical Center. Analysis of these cases revealed 30 patients (9.3% of the total) with disease of different histologic subtypes at separate anatomic sites (discordant lymphomas). On further analysis, 16 of these patients (4.8% of the total) were found to have disease of different histological and prognostic types. Recommendation is made that initial therapy be directed at the poor-prognosis component of these tumors. Relapses of both favorable prognostic types and unfavorable histologic types were seen, and further biopsy at the time of relapse is recommended in these cases.
1971年7月至1980年12月,323例非霍奇金淋巴瘤患者被随机纳入斯坦福大学医学中心的前瞻性临床试验。对这些病例的分析显示,有30例患者(占总数的9.3%)在不同解剖部位患有不同组织学亚型的疾病(不一致淋巴瘤)。进一步分析发现,其中16例患者(占总数的4.8%)患有不同组织学和预后类型的疾病。建议初始治疗针对这些肿瘤的预后不良成分。观察到预后良好类型和组织学类型不良的患者均出现复发,建议这些病例在复发时进行进一步活检。